DENDRID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dendrid, and when can generic versions of Dendrid launch?
Dendrid is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in DENDRID is idoxuridine. There are two drug master file entries for this compound. Additional details are available on the idoxuridine profile page.
Summary for DENDRID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 115 |
Patent Applications: | 4,089 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DENDRID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DENDRID
US Patents and Regulatory Information for DENDRID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | DENDRID | idoxuridine | SOLUTION/DROPS;OPHTHALMIC | 014169-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |